Comparison Chart Telix Pharmaceuticals Limited
Equities
TLX
AU000000TLX2
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.64 AUD | -2.40% |
|
0.00% | +30.71% |
| 04-17 | Telix Pharmaceuticals Says JPMorgan Increases Stake | MT |
| 04-16 | Telix Enters Attractive Market With Late-Stage Brain Cancer Drug Trial in US, Jefferies Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Other Biotechnology & Medical Research | -2.40% | 0.00% | +30.71% | -43.01% | +268.77% | 3.57B |  |  |  |
- Stock Market
- Equities
- TLX Stock
- Charts Telix Pharmaceuticals Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition